DE3376799D1 - Gel-like ointment containing indomethacin - Google Patents

Gel-like ointment containing indomethacin

Info

Publication number
DE3376799D1
DE3376799D1 DE8383112623T DE3376799T DE3376799D1 DE 3376799 D1 DE3376799 D1 DE 3376799D1 DE 8383112623 T DE8383112623 T DE 8383112623T DE 3376799 T DE3376799 T DE 3376799T DE 3376799 D1 DE3376799 D1 DE 3376799D1
Authority
DE
Germany
Prior art keywords
gel
water
ointment
indometacin
ointment containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383112623T
Other languages
German (de)
English (en)
Inventor
Pyare Seth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mepha GmbH
Original Assignee
Mepha GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha GmbH filed Critical Mepha GmbH
Application granted granted Critical
Publication of DE3376799D1 publication Critical patent/DE3376799D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE8383112623T 1983-08-29 1983-12-15 Gel-like ointment containing indomethacin Expired DE3376799D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH472683A CH643138A5 (de) 1983-08-29 1983-08-29 Indomethacin enthaltende, gelartige salbe.

Publications (1)

Publication Number Publication Date
DE3376799D1 true DE3376799D1 (en) 1988-07-07

Family

ID=4281430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383112623T Expired DE3376799D1 (en) 1983-08-29 1983-12-15 Gel-like ointment containing indomethacin

Country Status (11)

Country Link
US (1) US4540572A (enExample)
EP (1) EP0135617B1 (enExample)
JP (1) JPS6048921A (enExample)
AT (1) ATE34663T1 (enExample)
CH (1) CH643138A5 (enExample)
DE (1) DE3376799D1 (enExample)
DK (1) DK163911C (enExample)
IL (1) IL72649A (enExample)
NO (1) NO168564C (enExample)
SE (1) SE8404182L (enExample)
ZA (1) ZA846196B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US4762851A (en) * 1985-11-29 1988-08-09 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
AU7397887A (en) * 1986-05-09 1987-12-01 Sloan-Kettering Institute For Cancer Research Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
IT1222309B (it) * 1987-07-08 1990-09-05 Menarini Sas Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezione da germi sensibili alla miocamicina stessa
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US5073366A (en) * 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
US5294440A (en) * 1991-06-14 1994-03-15 Professional Pharmaceutical Inc. Composition for treatment of cold sores
US5599546A (en) * 1992-06-16 1997-02-04 Klein; Marvin E. Medicinal facial mask
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
JP2546478B2 (ja) * 1992-12-28 1996-10-23 日本電気株式会社 マイクロ波発振器
JP2533723B2 (ja) * 1992-12-28 1996-09-11 東興薬品工業株式会社 速乾性ゲルタイプ手指消毒剤
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6824795B2 (en) 2000-03-28 2004-11-30 Council Of Scientific And Industrial Research Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
US6514541B2 (en) 2000-03-28 2003-02-04 Council Of Scientific And Industrial Research Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20030228337A1 (en) * 2002-05-29 2003-12-11 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with hydroxy amine neutralized polymers
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
ITMI20041628A1 (it) * 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103833B1 (de) * 1971-01-27 1972-01-05 Merck & Co Ine , Rahway, N J (V St A) Äußerlich anzuwendendes entzundungs hemmendes Mittel
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
JPS5927478B2 (ja) * 1979-07-06 1984-07-05 富士空調工業株式会社 エルボの製造方法
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform
JPS5798209A (en) * 1980-12-09 1982-06-18 Kowa Co Remedy for dermatopathy for external use
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物

Also Published As

Publication number Publication date
DK163911C (da) 1992-09-14
JPH0237891B2 (enExample) 1990-08-28
NO843240L (no) 1985-03-01
DK163911B (da) 1992-04-21
NO168564C (no) 1992-03-11
IL72649A0 (en) 1984-11-30
SE8404182L (sv) 1985-03-01
JPS6048921A (ja) 1985-03-16
US4540572A (en) 1985-09-10
DK401584D0 (da) 1984-08-22
ATE34663T1 (de) 1988-06-15
SE8404182D0 (sv) 1984-08-22
NO168564B (no) 1991-12-02
IL72649A (en) 1987-12-20
DK401584A (da) 1985-03-01
CH643138A5 (de) 1984-05-30
EP0135617A1 (de) 1985-04-03
ZA846196B (en) 1985-03-27
EP0135617B1 (de) 1988-06-01

Similar Documents

Publication Publication Date Title
IL72649A (en) Gel-like ointment containing indometacin
AU581167B2 (en) Synthesis of oligosaccharides containing galactosamine-uronic acid patterns
AU553340B2 (en) Fast drying semi-rigid zinc oxide bandage
DE3277801D1 (en) Use of 4-aminosalicylic acid as an anti-inflammatory agent
ES2192586T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
EP0070048A3 (en) Tyrosine derivatives and chemical process for the preparation of these tyrosine derivatives
DE3582691D1 (de) Hautbehandlungsmittel.
IT8167777A0 (it) Composti farmaceutici atti ad inibire la biosintesi del colesterolo e procedimento per la loro preparazione
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
SE8505456D0 (sv) Gel dentifrice of desirable consistency
ATE67667T1 (de) Neue topische metronidazol-formulierungen.
IT1125479B (it) Trattamento del gas di spurgo nella sintesi della ammoniaca
ATE95419T1 (de) Alkohol enthaltende waessrige gelartige phospholipidzusammensetzung, ihre verwendung und topische zubereitungen, die diese enthalten.
JPS5562013A (en) Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
JPS5562014A (en) Aqueous poultice having no skin irritation effect
DE3373978D1 (en) Composition for the care or treatment of the human skin
RU96124181A (ru) Гель лечебно-профилактический
ES8608533A1 (es) Un fosfato de azucar
IT8025850A0 (it) Coadiuvante per promuovere l'absorbimento di sostanze farmacologicamente attive attraverso il retto, e composizione farmaceutica che lo comprendono.
DK0644767T3 (da) Veterinærprodukt til rehydratisering
JPS56169623A (en) Anti-inflammatory and pain-killing spreading plaster
IT1116518B (it) Composizione per prevenire o curare la dissenteria dei suini e relativo procedimento di impiego
JPS546861A (en) Dehydrating method for sludge
JPS57165313A (en) Indomethacin for external use
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee